Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)

Clinical trial NCT07166549 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07166549
Sponsor: University Hospital, Basel, Switzerland
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B Cell Malignancies B-cell Leukemia B Cell Lymphoma Bispecific Chimeric Antigen Receptor (CAR) T Cells Relapsed or Refractory (r/r) B-cell Malignancies

Start date: 2026-06-01
Primary completion: 2028-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.